Extrawell Pharmaceutical Holdings Limited Profile Avatar - Palmy Investing

Extrawell Pharmaceutical Holdings Limited

Extrawell Pharmaceutical Holdings Limited, an investment holding company, develops, manufactures, markets, distributes, and sells pharmaceutical products in the People's Republic of China. The company operates through Manufacturing, Trading, and Gene Dev…

Drug Manufacturers - Specialty & Generic
HK, Quarry Bay [HQ]

FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 28% Weak
Profitability n.A. n.A.
Fin. Growth n.A. n.A.
Leverage & Liquidity 33% Weak
Per Share Metrics 0% Bad
Fin. Health n.A. n.A.
1 Financial Health
Metric Q2 Q4 Δ in %
Current Ratio -1.00 3.45 3.49
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -85.13 67.85 456.18
Naive Interpretation member
2 Per Share
Metric Q2 Q4 Δ in %
Book Value 110.66 0.47 0.22
Cash -15.66 0.04 0.05
Capex 100.00 < 0.005 0.00
Free Cash Flow -66.36 < 0.005 < 0.005
Revenue -3.93 0.01 0.01
Naive Interpretation member
3 Profitability
Metric Q2 Q4 Δ in %
Gross Margin -2.92 0.48 0.49
Operating Margin -8.44 -0.12 -0.11
ROA -70.55 0.06 -0.20
ROE -85.08 0.07 -0.45
ROIC 4.42 < 0.005 < 0.005
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 0858.HK is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 0858.HK is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 0858.HK is permitted for members.
End of 0858.HK's Analysis
CIK: - CUSIP: - ISIN: BMG3285Q1134 LEI: - UEI: -
Secondary Listings
0858.HK has no secondary listings inside our databases.